Total Payments
$8,904
2024 Payments
$660.42
Companies
45
Transactions
389
Medicare Patients
6,858
Medicare Billing
$899,567
Payment Breakdown by Category
Food & Beverage$8,845 (99.3%)
Gifts$44.90 (0.5%)
Education$14.47 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,845 | 380 | 99.3% |
| Gift | $44.90 | 3 | 0.5% |
| Education | $14.47 | 2 | 0.2% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$8,904
385 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,555 | 97 | $0 (2023) |
| Janssen Biotech, Inc. | $937.75 | 60 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $845.91 | 32 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $606.96 | 38 | $0 (2024) |
| PFIZER INC. | $398.61 | 24 | $0 (2023) |
| Gilead Sciences, Inc. | $303.09 | 16 | $0 (2021) |
| Boston Scientific Corporation | $287.70 | 2 | $0 (2024) |
| Shire North American Group Inc | $222.71 | 13 | $0 (2019) |
| Romark Laboratories, LC | $196.05 | 8 | $0 (2020) |
| Covidien LP | $178.76 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $660.42 | 7 | Boston Scientific Corporation ($287.70) |
| 2023 | $1,090 | 39 | ABBVIE INC. ($420.86) |
| 2022 | $1,767 | 76 | ABBVIE INC. ($617.04) |
| 2021 | $1,227 | 56 | AbbVie Inc. ($401.45) |
| 2020 | $615.98 | 25 | Takeda Pharmaceuticals U.S.A., Inc. ($254.91) |
| 2019 | $1,093 | 64 | AbbVie, Inc. ($260.00) |
| 2018 | $1,125 | 57 | AbbVie, Inc. ($336.13) |
| 2017 | $1,326 | 65 | AbbVie, Inc. ($448.58) |
All Payment Transactions
389 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $119.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $146.97 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/14/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $128.35 | General |
| Category: Rare Disease | ||||||
| 03/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $107.78 | General |
| Category: Oncology | ||||||
| 01/30/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $140.73 | General |
| Category: EXALT_ENDO | ||||||
| 01/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Gastroenterology | ||||||
| 2024 | GastroGPO, LLC | — | — | — | $0.00 | Ownership |
| 11/16/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $119.25 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/19/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.02 | General |
| Category: Immunology | ||||||
| 10/05/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $24.99 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/20/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.72 | General |
| Category: Neuroscience | ||||||
| 09/08/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Immunology | ||||||
| 08/30/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Gastroenterology | ||||||
| 08/24/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/07/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2023 | Sandoz Inc. | HYRIMOZ (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: IMMUNOLOGY | ||||||
| 07/20/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: IMMUNOLOGY | ||||||
| 07/14/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Immunology | ||||||
| 07/11/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: Immunology | ||||||
| 07/11/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $24.96 | General |
| Category: THERAPY FOR CSID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,625 | 2,195 | $1.3M | $228,348 |
| 2022 | 23 | 1,812 | 2,415 | $1.4M | $253,198 |
| 2021 | 21 | 1,855 | 2,385 | $1.2M | $232,963 |
| 2020 | 17 | 1,566 | 2,198 | $846,239 | $185,058 |
Total Patients
6,858
Total Services
9,193
Medicare Billing
$899,567
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 212 | 212 | $302,100 | $45,968 | 15.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 247 | 693 | $138,600 | $44,440 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 232 | 320 | $67,840 | $28,786 | 42.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 188 | 194 | $58,200 | $20,279 | 34.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 195 | 203 | $187,675 | $16,753 | 8.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 115 | 116 | $144,384 | $15,177 | 10.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 75 | 75 | $106,894 | $14,206 | 13.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 48 | 48 | $67,526 | $8,890 | 13.2% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 58 | 66 | $49,500 | $6,988 | 14.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 79 | $11,850 | $5,122 | 43.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $14,432 | $4,821 | 33.4% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2023 | 23 | 24 | $27,600 | $4,047 | 14.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 47 | 48 | $43,200 | $3,724 | 8.6% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 13 | 15 | $24,750 | $3,163 | 12.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $26,180 | $3,151 | 12.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $5,500 | $1,862 | 33.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 14 | $1,400 | $971.36 | 69.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 237 | 237 | $337,725 | $49,261 | 14.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 274 | 738 | $147,600 | $43,432 | 29.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 204 | 281 | $59,572 | $27,527 | 46.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 195 | 207 | $62,100 | $22,701 | 36.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 77 | 78 | $110,546 | $15,086 | 13.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 206 | 212 | $190,800 | $14,495 | 7.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 73 | 73 | $104,682 | $13,955 | 13.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 90 | 90 | $111,510 | $11,281 | 10.1% |
About Dr. Robert Janda, MD
Dr. Robert Janda, MD is a Gastroenterology healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053426031.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Janda, MD has received a total of $8,904 in payments from pharmaceutical and medical device companies, with $660.42 received in 2024. These payments were reported across 389 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($8,845).
As a Medicare-enrolled provider, Janda has provided services to 6,858 Medicare beneficiaries, totaling 9,193 services with total Medicare billing of $899,567. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Fort Myers, FL
- Active Since 08/20/2006
- Last Updated 01/05/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1053426031
Products in Payments
- STELARA (Biological) $1,039
- SKYRIZI (Biological) $483.65
- XIFAXAN (Drug) $468.68
- ENTYVIO (Biological) $446.82
- XELJANZ (Drug) $398.61
- Humira (Biological) $374.59
- GATTEX (Drug) $344.82
- RINVOQ (Biological) $325.31
- ZEPOSIA (Drug) $272.12
- HUMIRA (Biological) $264.17
- Cimzia (Drug) $164.68
- Smart Pill (Device) $164.17
- Alinia Tablets 500mg 30 count bottle (Drug) $156.62
- TRULANCE (Drug) $155.66
- Entyvio (Biological) $147.07
- WATCHMAN FLX (Device) $146.97
- LINZESS (Drug) $143.74
- VIBERZI (Drug) $141.00
- EXALT Model D (Device) $140.73
- Creon (Drug) $131.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fort Myers
Randall Jacobs, Md, MD
Gastroenterology — Payments: $18,306
Gastroenterology $18,306
Juan Tejada-Almonte, M.d, M.D
Gastroenterology — Payments: $13,404
Gastroenterology $13,404
Dr. Augustine Salami, Md, MD
Gastroenterology — Payments: $10,902
Gastroenterology $10,902
Dr. Edward Jurkovic, D.o, D.O
Gastroenterology — Payments: $9,721
Gastroenterology $9,721
David Elliott, Do, DO
Gastroenterology — Payments: $8,680
Gastroenterology $8,680
Ramesh Koka, M.d, M.D
Gastroenterology — Payments: $8,404
Gastroenterology $8,404